findmyKOL
Clinical trialNCT06470815TerminatedObservational

ROADSTER 3 Extended Follow-up Sub-Study

SponsorSilk Road MedicalEnrollment197Carotid Artery Diseases
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The study objective is to evaluate long-term outcomes for participants enrolled in the ROADSTER 3 study and treated with the ENROUTE Transcarotid Stent System (TSS) and ENROUTE Transcarotid Neuroprotection System (NPS).

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

37 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Valley Vascular Consultants

    Huntsville, Alabama, United States

  • Honorhealth

    Scottsdale, Arizona, United States

  • Pima Heart & Vascular

    Tucson, Arizona, United States

  • University of California, San Diego (ucsd)

    La Jolla, California, United States

  • Sharp Grossmont

    La Mesa, California, United States

  • Morton Plant Hospital

    Clearwater, Florida, United States

  • Delray Medical Center

    Delray Beach, Florida, United States

  • Mount Sinai Medical Center

    Miami Beach, Florida, United States

  • Adventhealth Ocala

    Ocala, Florida, United States

  • Northside Vascular

    Cumming, Georgia, United States

  • Deaconess Research / Evansville Surgical Associates

    Evansville, Indiana, United States

  • Indiana University

    Indianapolis, Indiana, United States

  • Acadiana Vascular Clinic / Our Lady Lourdes Heart Hospital

    Lafayette, Louisiana, United States

  • Maine Medical Center

    Portland, Maine, United States

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, United States

  • Mclaren Heart & Vascular

    Bay City, Michigan, United States

  • Corewell Health

    Grand Rapids, Michigan, United States

  • Abbott Northwestern

    Minneapolis, Minnesota, United States

  • St. Luke'S Hospital

    Chesterfield, Missouri, United States

  • Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire, United States

  • Hackensack University Medical Center

    Hackensack, New Jersey, United States

  • New York University

    New York, New York, United States

  • the Mount Sinai Hospital

    New York, New York, United States

  • University of Rochester

    Rochester, New York, United States

  • Bethesda North Hospital

    Cincinnati, Ohio, United States

  • Providence Portland Medical Center-Hospital

    Portland, Oregon, United States

  • St. Luke'S University Hospital

    Bethlehem, Pennsylvania, United States

  • Upmc Pinnacle

    Harrisburg, Pennsylvania, United States

  • Lancaster General Hospital

    Lancaster, Pennsylvania, United States

  • Allegheny General Hospital

    Pittsburgh, Pennsylvania, United States

  • Medical University of South Carolina (musc)

    Charleston, South Carolina, United States

  • Cardiothoracic and Vascular Surgeons

    Austin, Texas, United States

  • Memorial Hermann Southeast

    Houston, Texas, United States

  • Houston Methodist Sugarland

    Sugarland, Texas, United States

  • Sentara

    Norfolk, Virginia, United States

  • Carilion Roanoke Memorial

    Roanoke, Virginia, United States

  • Charleston Area Medical Center (camc)

    Charleston, West Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jul 2024
Primary completion
31 Dec 2025
Completion
31 Dec 2025
Last update posted
16 Jul 2026
Registered enrollment
197
Registry id
NCT06470815

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.